Related Experiment Video

Updated: Aug 4, 2026

Transgenic Rodent Assay for Quantifying Male Germ Cell Mutant Frequency
14:45

Transgenic Rodent Assay for Quantifying Male Germ Cell Mutant Frequency

Published on: August 6, 2014

Studies in mice on the mutagenicity of two contraceptive drugs

M E Wallace, F M Badr, R S Badr

    Journal of Medical Genetics
    |June 1, 1979
    PubMed

    Insights

    This study found no evidence that Gynanovlar or Lyndiol contraceptives cause genetic mutations in mice. Researchers observed no increase in lethal or visible mutations after exposure to these reproductive health drugs.

    Area of Science:

    • Toxicology
    • Genetics
    • Reproductive Health

    Background:

    • Contraceptive drugs require rigorous safety testing for mutagenic potential.
    • Previous research on oral contraceptives and mutagenicity has yielded varied results.
    • Understanding the genetic impact of hormonal contraceptives is crucial for public health.

    Purpose of the Study:

    • To evaluate the mutagenic effects of Gynanovlar and Lyndiol in a mouse model.
    • To assess the incidence of visible and invisible mutations following exposure to different contraceptive doses.
    • To establish the safety profile of these contraceptives regarding genetic damage.

    Main Methods:

    • Mice (CBA/CagCam substrain) were administered four escalating doses of Gynanovlar and Lyndiol.
    • Mutagenic effects were assessed by observing antenatal and postnatal lethal mutations.
    • Visible mutations and skeletal abnormalities were meticulously recorded and analyzed.

    Main Results:

    • No statistically significant increase in antenatal or postnatal lethals was observed.
    • No significant increase in visible mutations was detected in treated mice compared to controls.
    • The CBA/CagCam substrain exhibited a baseline incidence of skeletal abnormalities (0.27%).

    Conclusions:

    • Gynanovlar and Lyndiol do not appear to possess appreciable mutagenic effects in mice.
    • The study supports the safety of these contraceptives concerning genetic mutations.
    • Further research may explore long-term effects or different exposure routes.

    More Related Videos

    The Lambda Select cII Mutation Detection System07:08

    The Lambda Select cII Mutation Detection System

    Published on: April 26, 2018

    Determination of Reproductive Competence by Confirming Pubertal Onset and Performing a Fertility Assay in Mice and Rats06:38

    Determination of Reproductive Competence by Confirming Pubertal Onset and Performing a Fertility Assay in Mice and Rats

    Published on: October 13, 2018

    Related Concept Videos

    In-vitro Mutagenesis01:16

    In-vitro Mutagenesis

    To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
    Mouse Models of Cancer Study02:43

    Mouse Models of Cancer Study

    Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
    The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
    Mutagenicity and Carcinogenicity01:25

    Mutagenicity and Carcinogenicity

    Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
    Toxicity Testing in Animals01:23

    Toxicity Testing in Animals

    Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...